Elham Soltanmohammadi

Elham Soltanmohammadi, PhD, is a Pharmaceutical Specialist at Navega Therapeutics since November 2021. Prior to this role, Elham was a PhD candidate and researcher at the University of South Carolina, focusing on pharmaceutical science, drug design, and breast cancer. Elham has experience as a research assistant at IRAN University of Medical Sciences, working on genomics in cardiovascular disease and the relationship between SREBP-2, lipid profile, and PCSK9. Additionally, Elham served as a General Laboratory Supervisor at Soorena Hospital, where responsibilities included coordinating laboratory activities and implementing policies and procedures. Elham holds a Doctor of Philosophy degree in Pharmaceutics and Drug Design from the University of South Carolina, along with education from Tehran University of Medical Sciences and IRAN University of Medical Sciences.